Earnings Releases·Nov 9, 2026, 4:07 PM ET

National Health Investors, Inc. — Third Quarter 2026 Earnings Summary

Net income per diluted share surged to $11.47 for the quarter and $13.52 for the nine months ended September 30, 2026, compared to $0.69 and $2.22 respectively in the prior year, driven by a $541.6 million gain on the July 2026 sale of the NHC leased portfolio and total disposition gains of $567.5 million.
NAREIT FFO per diluted share increased 2.8% to $1.12 for the quarter and 3.5% to $3.54 for the nine months, while Normalized FFO per diluted share decreased 15.2% to $1.12 for the quarter and 4.1% to $3.54 for the nine months due to transaction costs and impairments.
The Company reaffirmed full-year 2026 guidance ranges, including Net income of $687.0 million to $687.6 million and NAREIT FFO per diluted share of $4.68 to $4.70, assuming $190 million in new investments and continued commitment fulfillment.
Strategic activity included the acquisition of 20 SHOP segment properties since Q4 2025 and three new acquisitions in October 2026 totaling $159.1 million, alongside the sale of 42 properties in the Real Estate Investments segment for $672.1 million year-to-date.
The Board declared a $0.94 per share dividend payable in January 2027; the Company maintains investment-grade credit ratings, $1.0 billion in consolidated net debt, and $500 million available under its ATM equity program.